Alexandra Calmy
Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients
Abela I, Günthard H, Bernasconi E, Cavassini M, Schmid P, Calmy A, Furrer H, Hirsch H, Perreau M, Klimkait T, Yerly S, Böni J, Scherrer A, Swiss HIV Cohort Study. Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients. Clin Infect Dis 2020; 70:297-303.
02.01.2020Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients
02.01.2020Clin Infect Dis 2020; 70:297-303
Abela Irene A, Günthard Huldrych F, Bernasconi Enos, Cavassini Matthias, Schmid Patrick, Calmy Alexandra, Furrer Hansjakob, Hirsch Hans H, Perreau Matthieu, Klimkait Thomas, Yerly Sabine, Böni Jürg, Scherrer Alexandra U, Swiss HIV Cohort Study
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Olearo F, D'arminio Monforte A, Zazzi M, Rossetti B, Neau D, Bellecave P, Rijnders B, Reiss P, Wit F, Kouyos R, Boeni J, Bernasconi E, Günthard H, Nguyen H, Bonnet F, Yerly S, Wandeler G, Stoeckle M, Cavassini M, Scherrer A, Costagliola D, Schmid P, Calmy A. Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients. Open Forum Infect Dis 2019; 6:ofz500.
08.12.2019Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
08.12.2019Open Forum Infect Dis 2019; 6:ofz500
Olearo Flaminia, D'arminio Monforte Antonella, Zazzi Maurizio, Rossetti Barbara, Neau Didier, Bellecave Pantxika, Rijnders Bart, Reiss Peter, Wit Ferdinand, Kouyos Roger, Boeni Jürg, Bernasconi Enos, Günthard Huldrych F, Nguyen Huyen, Bonnet Fabrice, Yerly Sabine, Wandeler Gilles, Stoeckle Marcel, Cavassini Matthias, Scherrer Alexandra, Costagliola Dominique, Schmid Patrick, Calmy Alexandra
Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017
Ruffieux Y, Egger M, Keiser O, Vernazza P, Scherrer A, Marzolini C, Günthard H, Fux C, Cavassini M, Calmy A, Aebi-Popp K, Lemsalu L, Swiss HIV Cohort Study and the Swiss National Cohort. Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017. J Int AIDS Soc 2019; 22:e25339.
01.08.2019Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017
01.08.2019J Int AIDS Soc 2019; 22:e25339
Ruffieux Yann, Egger Matthias, Keiser Olivia, Vernazza Pietro, Scherrer Alexandra, Marzolini Catia, Günthard Huldrych F, Fux Christoph A, Cavassini Matthias, Calmy Alexandra, Aebi-Popp Karoline, Lemsalu Liis, Swiss HIV Cohort Study and the Swiss National Cohort
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Olearo F, D'arminio Monforte A, Zazzi M, Rossetti B, Neau D, Bellecave P, Rijnders B, Reiss P, Wit F, Kouyos R, Boeni J, Bernasconi E, Günthard H, Nguyen H, Bonnet F, Yerly S, Wandeler G, Stoeckle M, Cavassini M, Scherrer A, Costagiola D, Schmid P, Calmy A. Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients. Open Forum Infect Dis 2019; 6:ofz330.
12.07.2019Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
12.07.2019Open Forum Infect Dis 2019; 6:ofz330
Olearo Flaminia, D'arminio Monforte Antonella, Zazzi Maurizio, Rossetti Barbara, Neau Didier, Bellecave Pantxika, Rijnders Bart, Reiss Peter, Wit Ferdinand, Kouyos Roger, Boeni Jürg, Bernasconi Enos, Günthard Huldrych F, Nguyen Huyen, Bonnet Fabrice, Yerly Sabine, Wandeler Gilles, Stoeckle Marcel, Cavassini Matthias, Scherrer Alexandra, Costagiola Dominique, Schmid Patrick, Calmy Alexandra
Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland
Santos G, Cavassini M, Du Pasquier R, Darling K, Schmid P, Di Benedetto C, Fux C, Stoeckle M, Tarr P, Kovari H, Hasse B, Cusini A, Hauser C, Nadin I, Lecompte T, Calmy A, Métral M, Locatelli I, Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) Study Group. Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland. Open Forum Infect Dis 2019; 6:ofz277.
08.07.2019Cross-Sectional and Cumulative Longitudinal Central Nervous System Penetration Effectiveness Scores Are Not Associated With Neurocognitive Impairment in a Well Treated Aging Human Immunodeficiency Virus-Positive Population in Switzerland
08.07.2019Open Forum Infect Dis 2019; 6:ofz277
Santos Galia M A, Cavassini Matthias, Du Pasquier Renaud, Darling Katharine E A, Schmid Patrick, Di Benedetto Caroline, Fux Christoph, Stoeckle Marcel, Tarr Philip, Kovari Helen, Hasse Barbara, Cusini Alexia, Hauser Christoph, Nadin Isaure, Lecompte Thanh Doco, Calmy Alexandra, Métral Mélanie, Locatelli Isabella, Neurocognitive Assessment in the Metabolic and Aging Cohort (NAMACO) Study Group
The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study
Young J, Bucher H, Günthard H, Vernazza P, Hachfeld A, Cavassini M, Bernasconi E, Tarr P, Calmy A, Scherrer A, Swiss HIV Cohort Study. The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study. Antivir Ther (Lond) 2019
15.04.2019The comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study
15.04.2019Antivir Ther (Lond) 2019
Young Jim, Bucher Heiner C, Günthard Huldrych F, Vernazza Pietro, Hachfeld Anna, Cavassini Matthias, Bernasconi Enos, Tarr Philip E, Calmy Alexandra, Scherrer Alexandra U, Swiss HIV Cohort Study
Viral diversity from next-generation sequencing of HIV-1 samples provides precise estimates of infection recency and time since infection
Carlisle L, Braun D, Rauch A, Calmy A, Cavassini M, Battegay M, Vernazza P, Bernasconi E, Günthard H, Kouyos R, Perreau M, Klimkait T, Yerly S, Turk T, Kusejko K, Metzner K, Leemann C, Schenkel C, Bachmann N, Posada S, Beerenwinkel N, Böni J, Swiss HIV Cohort Study. Viral diversity from next-generation sequencing of HIV-1 samples provides precise estimates of infection recency and time since infection. J Infect Dis 2019
04.03.2019Viral diversity from next-generation sequencing of HIV-1 samples provides precise estimates of infection recency and time since infection
04.03.2019J Infect Dis 2019
Carlisle Louisa A, Braun Dominique L, Rauch Andri, Calmy Alexandra, Cavassini Matthias, Battegay Manuel, Vernazza Pietro, Bernasconi Enos, Günthard Huldrych F, Kouyos Roger D, Perreau Matthieu, Klimkait Thomas, Yerly Sabine, Turk Teja, Kusejko Katharina, Metzner Karin J, Leemann Christine, Schenkel Corinne, Bachmann Nadine, Posada Susana, Beerenwinkel Niko, Böni Jürg, Swiss HIV Cohort Study
Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study
Kusejko K, Kouyos R, Günthard H, Rauch A, Perreau M, Klimkait T, Yerly S, Böni J, Hoffmann M, Cavassini M, Calmy A, Bernasconi E, Battegay M, Marzel A, Kadelka C, Swiss HIV Cohort Study. Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study. Virus Evol 2018; 4:vey024.
18.09.2018Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study
18.09.2018Virus Evol 2018; 4:vey024
Kusejko Katharina, Kouyos Roger D, Günthard Huldrych F, Rauch Andri, Perreau Matthieu, Klimkait Thomas, Yerly Sabine, Böni Jürg, Hoffmann Matthias, Cavassini Matthias, Calmy Alexandra, Bernasconi Enos, Battegay Manuel, Marzel Alex, Kadelka Claus, Swiss HIV Cohort Study
Tracing HIV-1 strains that imprint broadly neutralizing antibody responses
Kouyos R, Cavassini M, Bernasconi E, Hoffmann M, Calmy A, Battegay M, Rauch A, Yerly S, Aubert V, Klimkait T, Böni J, Metzner K, Günthard H, Trkola A, Chave J, Kuster H, Leemann C, Rusert P, Kadelka C, Huber M, Marzel A, Ebner H, Schanz M, Liechti T, Friedrich N, Braun D, Scherrer A, Weber J, Uhr T, Baumann N, Swiss HIV Cohort Study. Tracing HIV-1 strains that imprint broadly neutralizing antibody responses. Nature 2018; 561:406-410.
10.09.2018Tracing HIV-1 strains that imprint broadly neutralizing antibody responses
10.09.2018Nature 2018; 561:406-410
Kouyos Roger D, Cavassini Matthias, Bernasconi Enos, Hoffmann Matthias, Calmy Alexandra, Battegay Manuel, Rauch Andri, Yerly Sabine, Aubert Vincent, Klimkait Thomas, Böni Jürg, Metzner Karin J, Günthard Huldrych F, Trkola Alexandra, Chave Jean-Philippe, Kuster Herbert, Leemann Christine, Rusert Peter, Kadelka Claus, Huber Michael, Marzel Alex, Ebner Hanna, Schanz Merle, Liechti Thomas, Friedrich Nikolas, Braun Dominique L, Scherrer Alexandra U, Weber Jacqueline, Uhr Therese, Baumann Nicolas S, Swiss HIV Cohort Study
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity
Kadelka C, Bernasconi E, Hoffmann M, Calmy A, Battegay M, Rauch A, Yerly S, Aubert V, Klimkait T, Böni J, Kouyos R, Günthard H, Trkola A, Cavassini M, Misselwitz B, Liechti T, Ebner H, Schanz M, Rusert P, Friedrich N, Stiegeler E, Braun D, Huber M, Scherrer A, Weber J, Uhr T, Kuster H, Swiss HIV Cohort Study. Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity. J Exp Med 2018; 215:1589-1608.
24.05.2018Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity
24.05.2018J Exp Med 2018; 215:1589-1608
Kadelka Claus, Bernasconi Enos, Hoffmann Matthias, Calmy Alexandra, Battegay Manuel, Rauch Andri, Yerly Sabine, Aubert Vincent, Klimkait Thomas, Böni Jürg, Kouyos Roger D, Günthard Huldrych F, Trkola Alexandra, Cavassini Matthias, Misselwitz Benjamin, Liechti Thomas, Ebner Hanna, Schanz Merle, Rusert Peter, Friedrich Nikolas, Stiegeler Emanuel, Braun Dominique L, Huber Michael, Scherrer Alexandra U, Weber Jacqueline, Uhr Therese, Kuster Herbert, Swiss HIV Cohort Study
The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic Analysis
Marzel A, Kouyos R, Günthard H, Perreau M, Klimkait T, Yerly S, Böni J, Hoffmann M, Cavassini M, Calmy A, Bernasconi E, Roth J, Rauch A, Bruggmann P, Weber R, Kusejko K, Swiss HIV Cohort Study. The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic Analysis. Open Forum Infect Dis 2018; 5:ofy078.
19.05.2018The Cumulative Impact of Harm Reduction on the Swiss HIV Epidemic: Cohort Study, Mathematical Model, and Phylogenetic Analysis
19.05.2018Open Forum Infect Dis 2018; 5:ofy078
Marzel Alex, Kouyos Roger D, Günthard Huldrych F, Perreau Matthieu, Klimkait Thomas, Yerly Sabine, Böni Jürg, Hoffmann Matthias, Cavassini Matthias, Calmy Alexandra, Bernasconi Enos, Roth Jan A, Rauch Andri, Bruggmann Philip, Weber Rainer, Kusejko Katharina, Swiss HIV Cohort Study
Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID Study
Bouatou Y, Calmy A, de Seigneux S, Fux C, Kovari H, Merz L, Staehelin C, Hoffmann M, Battegay M, Bernasconi E, Gayet Ageron A, Swiss HIV Cohort Study. Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID Study. Kidney Int Rep 2018; 3:1089-1099.
08.05.2018Lipodystrophy Increases the Risk of CKD Development in HIV-Positive Patients in Switzerland: The LIPOKID Study
08.05.2018Kidney Int Rep 2018; 3:1089-1099
Bouatou Yassine, Calmy Alexandra, de Seigneux Sophie, Fux Christoph, Kovari Helen, Merz Laurent, Staehelin Cornelia, Hoffmann Matthias, Battegay Manuel, Bernasconi Enos, Gayet Ageron Angele, Swiss HIV Cohort Study
Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite Pathogenicity
Bertels F, Cavassini M, Calmy A, Bernasconi E, Schmid P, Scherrer A, Müller V, Bonhoeffer S, Kouyos R, Regoes R, Rauch A, Battegay M, Marzel A, Leventhal G, Mitov V, Fellay J, Günthard H, Böni J, Yerly S, Klimkait T, Aubert V, Swiss HIV Cohort Study. Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite Pathogenicity. Mol Biol Evol 2018; 35:27-37.
01.01.2018Dissecting HIV Virulence: Heritability of Setpoint Viral Load, CD4+ T-Cell Decline, and Per-Parasite Pathogenicity
01.01.2018Mol Biol Evol 2018; 35:27-37
Bertels Frederic, Cavassini Matthias, Calmy Alexandra, Bernasconi Enos, Schmid Patrick, Scherrer Alexandra U, Müller Viktor, Bonhoeffer Sebastian, Kouyos Roger, Regoes Roland R, Rauch Andri, Battegay Manuel, Marzel Alex, Leventhal Gabriel, Mitov Venelin, Fellay Jacques, Günthard Huldrych F, Böni Jürg, Yerly Sabine, Klimkait Thomas, Aubert Vincent, Swiss HIV Cohort Study
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis
Yerly S, Marzolini C, Martinez de Tejada B, Martinetti G, Ledergerber B, Kovari H, Kouyos R, Klimkait T, Keiser O, Kaiser L, Kahlert C, Hösli I, Hoffmann M, Hirsch H, Hasse B, Metzner K, Müller N, Weber R, Wandeler G, Vernazza P, Trkola A, Tarr P, Stöckle M, Speck R, Schmid P, Scherrer A, Rudin C, Rauch A, Paioni P, Pantaleo G, Nicca D, Haerry D, Günthard H, Fux C, Kouyos R, Günthard H, Hoffmann M, Furrer H, Cavassini M, Calmy A, Bernasconi E, Battegay M, Klimkait T, Aubert V, Yerly S, Böni J, Kadelka C, Bachmann N, Swiss HIV Cohort Study, Aubert V, Furrer H, Fellay J, Fehr J, Elzi L, Egger M, Dollenmaier G, Ciuffi A, Cavassini M, Calmy A, Bucher H, Braun D, Böni J, Bernasconi E, Battegay M, Turk T. Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis. Elife 2017; 6
12.09.2017Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis
12.09.2017Elife 2017; 6
Yerly S, Marzolini C, Martinez de Tejada B, Martinetti G, Ledergerber B, Kovari H, Kouyos R D, Klimkait T, Keiser O, Kaiser L, Kahlert Christian, Hösli I, Hoffmann M, Hirsch H H, Hasse B, Metzner K J, Müller N, Weber R, Wandeler G, Vernazza Pietro, Trkola A, Tarr P, Stöckle M, Speck R, Schmid Patrick, Scherrer A U, Rudin C, Rauch A, Paioni P, Pantaleo G, Nicca D, Haerry D, Günthard H F, Fux C A, Kouyos Roger D, Günthard Huldrych F, Hoffmann Matthias, Furrer Hansjakob, Cavassini Matthias, Calmy Alexandra, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Aubert Vincent, Yerly Sabine, Böni Jürg, Kadelka Claus, Bachmann Nadine, Swiss HIV Cohort Study, Aubert V, Furrer H, Fellay J, Fehr J, Elzi L, Egger M, Dollenmaier G, Ciuffi A, Cavassini M, Calmy A, Bucher H C, Braun D L, Böni J, Bernasconi E, Battegay M, Turk Teja
Adverse events of raltegravir and dolutegravir
Elzi L, Battegay M, Bernasconi E, Günthard H, Vernazza P, Calmy A, Cavassini M, Furrer H, Erb S. Adverse events of raltegravir and dolutegravir. AIDS 2017; 31:1853-1858.
24.08.2017Adverse events of raltegravir and dolutegravir
24.08.2017AIDS 2017; 31:1853-1858
Elzi Luigia, Battegay Manuel, Bernasconi Enos, Günthard Huldrych, Vernazza Pietro, Calmy Alexandra, Cavassini Matthias, Furrer Hansjakob, Erb Stefan
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study
Sculier D, Calmy A, Bernasconi E, Schmid P, Hirzel C, Fehr J, Cavassini M, Battegay M, Gayet-Ageron A, Swiss HIV Cohort Study. Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study. BMC Infect Dis 2017; 17:476.
06.07.2017Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study
06.07.2017BMC Infect Dis 2017; 17:476
Sculier Delphine, Calmy Alexandra, Bernasconi Enos, Schmid Patrick, Hirzel Cédric, Fehr Jan, Cavassini Matthias, Battegay Manuel, Gayet-Ageron Angèle, Swiss HIV Cohort Study
Human papillomavirus antibody response following HAART initiation among MSM
Combes J, Scherrer A, Waterboer T, Franceschi S, Günthard H, Bernasconi E, Schmid P, Calmy A, Hauser C, Hirsch H, Cavassini M, Egger M, Clifford G, Swiss HIV Cohort Study. Human papillomavirus antibody response following HAART initiation among MSM. AIDS 2017; 31:561-569.
20.02.2017Human papillomavirus antibody response following HAART initiation among MSM
20.02.2017AIDS 2017; 31:561-569
Combes Jean-Damien, Scherrer Alexandra U, Waterboer Tim, Franceschi Silvia, Günthard Huldrych F, Bernasconi Enos, Schmid Patrick, Calmy Alexandra, Hauser Christoph, Hirsch Hans H, Cavassini Matthias, Egger Matthias, Clifford Gary M, Swiss HIV Cohort Study
Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study
Béguelin C, Wandeler G, Rauch A, Atkinson A, Calmy A, Schmid P, Bernasconi E, Battegay M, Günthard H, Cavassini M, Lüthi A, Suter-Riniker F, Sahli R, Moradpour D, Friolet N. Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study. Clin Infect Dis 2017
11.02.2017Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study
11.02.2017Clin Infect Dis 2017
Béguelin Charles, Wandeler Gilles, Rauch Andri, Atkinson Andrew, Calmy Alexandra, Schmid Patrick, Bernasconi Enos, Battegay Manuel, Günthard Huldrych F, Cavassini Matthias, Lüthi Alexander, Suter-Riniker Franziska, Sahli Roland, Moradpour Darius, Friolet Nicole
Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals
Shilaih M, Kouyos R, Günthard H, Thurnheer M, Bernasconi E, Hoffmann M, Battegay M, Darling K, Calmy A, Young J, Kovari H, Scherrer A, Braun D, Marzel A. Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals. Medicine (Baltimore) 2017; 96:e5849.
01.01.2017Factors associated with syphilis incidence in the HIV-infected in the era of highly active antiretrovirals
01.01.2017Medicine (Baltimore) 2017; 96:e5849
Shilaih Mohaned, Kouyos Roger D, Günthard Huldrych F, Thurnheer Maria C, Bernasconi Enos, Hoffmann Matthias, Battegay Manuel, Darling Katharine, Calmy Alexandra, Young Jim, Kovari Helen, Scherrer Alexandra U, Braun Dominique L, Marzel Alex
Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population
Gueler A, Egger M, Zwahlen M, Vernazza P, Cavassini M, Battegay M, Fux C, Furrer H, Bernasconi E, Günthard H, Calmy A, Moser A. Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population. AIDS 2016
07.11.2016Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population
07.11.2016AIDS 2016
Gueler Aysel, Egger Matthias, Zwahlen Marcel, Vernazza Pietro, Cavassini Matthias, Battegay Manuel, Fux Christoph A, Furrer Hansjakob, Bernasconi Enos, Günthard Huldrych F, Calmy Alexandra, Moser André